Medrel Pharmaceuticals (India) Private Limited

Medrel Pharmaceuticals (India) Private Limited - pharma in Mumbai, Maharashtra, India. Directors, charges & compliance details.
CIN U24230MH1998PTC116233 Incorporated 13 August 1998 ROC Mumbai HQ Mumbai, Maharashtra, India
Under Liquidation Private Limited Company pharma
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Open charges
₹2.5 Lakh
Secured borrowings
Company age
28 yrs
Est. 1998
Directors on board
2
As per MCA filings
Last financials
Mar 2010
Balance sheet date
Last AGM
30 Sep 2010
Annual general meeting
Company status
Under Liquidation
MCA master data

About Medrel Pharmaceuticals (India) Private Limited

Data last updated:

Medrel Pharmaceuticals (India) Private Limited is a private limited company based in Mumbai, Maharashtra, India. The company is currently under liquidation, meaning its assets are being sold to settle outstanding debts. It may not have the legal capacity to fulfil new contracts. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 August 1998.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1998PTC116233.

The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Akshay Girjashankar Mehta and Mona Akshay Mehta.

Its last annual general meeting (AGM) was held on 30 September 2010, and its latest financial statements are for the year ended 31 March 2010. The registered office is at 54 – B Drug Houseprocter Road, Mumbai, Maharashtra, India – 400007.

As per MCA filings, the company has open charges of ₹2.5 Lakh on record. Court records list 10 cases involving the company, including 10 filed against it; 1 case is pending.

Company details

CIN U24230MH1998PTC116233
Registration Number 116233
Incorporation Date 13 August 1998
ROC Mumbai
Listing Status Unlisted
Company Status Under Liquidation

Contact details

Medrel Pharmaceuticals (India) Private Limited's registered office is in Mumbai, Maharashtra.

  • Registered Address
    54 – B Drug Houseprocter Road, Mumbai, Maharashtra, India – 400007
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
Medrel Pharmaceuticals (India) Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Medrel Pharmaceuticals (India) Private Limited

FY 2010 filings available

Financial Statement Summary

MetricsFY 2009-10
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA
Profit Before Tax
Tax Expense
Net Profit (PAT)
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2009-10
Profitability
EBITDA Margin
Net Profit Margin
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Medrel Pharmaceuticals (India) Private Limited, buy the company report.

Board of directors of Medrel Pharmaceuticals (India) Private Limited

Medrel Pharmaceuticals (India) has 2 directors on record. No former directors are listed.

Directors (as last reported)
NameDesignationAppointment DateTenureStatus
Akshay Girjashankar MehtaDirector13 Aug 199828 Years 3 MonthsAs last reported
Mona Akshay MehtaDirector13 Aug 199828 Years 3 MonthsAs last reported

Charges & borrowings

Open charges
₹2.5 Lakh
Satisfied charges
None
Breakdown by lending institutions
Citi Bank N a₹0.03 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
21 Apr 200490149522Citi Bank N a₹2.5 LakhOpen

Total charge records: 1 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Medrel Pharmaceuticals (India) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Medrel Pharmaceuticals (India) Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Medrel Pharmaceuticals (India) Private Limited has 2 board changes on record since 1998: 2 appointments. The latest: Akshay Girjashankar Mehta was appointed as Director on 13 Aug 1998.

AGM
Medrel Pharmaceuticals (India) Private Limited last Annual general meeting of members was held on 30 Sep 2010 as per latest MCA records.
Filing
Medrel Pharmaceuticals (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2010 with Roc Mumbai.
Charges
A charge with Citi Bank N A amounted to Rs. 2.50 Lakh with Charge ID 90149522 was registered on 21 Apr 2004.
Appointed
Akshay Girjashankar Mehta was appointed as Director.
Appointed
Mona Akshay Mehta was appointed as Director.
Incorporation
13 Aug 1998
Medrel Pharmaceuticals (India) Private Limited was registered on 13 Aug 1998 with Roc Mumbai & aged 28 years 3 months as per MCA records.

Frequently asked questions

Medrel Pharmaceuticals (India) is currently "Under Liquidation" as per MCA records. The company's assets are being sold to settle outstanding debts owed to creditors. A company under liquidation may not have the legal capacity to fulfil new contracts, and creditors are prioritised in the distribution of proceeds. This is a high-risk status - caution is strongly advised.

Medrel Pharmaceuticals (India) is a company under liquidation, formerly operating as a private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 13 August 1998 and is registered under CIN U24230MH1998PTC116233. Caution is advised - the company may not have the legal capacity to fulfil new agreements.

Medrel Pharmaceuticals (India) has 2 current directors:

The latest financial statements of Medrel Pharmaceuticals (India) on record with the MCA are for the year ended 31 March 2010. Its last annual general meeting was held on 30 September 2010. Year-wise statements from 2015 are in the company report.

The CIN (Corporate Identification Number) of Medrel Pharmaceuticals (India) is U24230MH1998PTC116233. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Medrel Pharmaceuticals (India) has open charges of ₹2.5 Lakh and no satisfied charges on record as per latest MCA filings.

Medrel Pharmaceuticals (India) has 10 court cases on record: 10 filed against it. 1 is pending. Most are in the district courts.

Medrel Pharmaceuticals (India) was incorporated on 13 August 1998. It is registered with the Registrar of Companies, Mumbai.

Akshay Girjashankar Mehta was appointed as Director on 13 Aug 1998. Mona Akshay Mehta was appointed as Director on 13 Aug 1998.

The registered office of Medrel Pharmaceuticals (India) is at 54 – B Drug Houseprocter Road, Mumbai, Maharashtra, India – 400007.